![]() |
Volumn 72, Issue 4, 2013, Pages 590-595
|
Defining erosive disease typical of RA in the light of the ACR/EULAR 2010 criteria for rheumatoid arthritis; results of the data driven phase
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
METHOTREXATE;
ADULT;
ARTICLE;
CONTROLLED STUDY;
DATA ANALYSIS;
DISEASE ASSOCIATION;
DISEASE CLASSIFICATION;
DISEASE DURATION;
DRUG EFFECT;
DRUG RESPONSE;
FEMALE;
FOLLOW UP;
FOOT RADIOGRAPHY;
HAND RADIOGRAPHY;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL DECISION MAKING;
OUTCOME ASSESSMENT;
PATIENT ASSESSMENT;
PREDICTIVE VALUE;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SENSITIVITY AND SPECIFICITY;
SYNDROME DELINEATION;
ADULT;
AGED;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
ARTHROGRAPHY;
DIAGNOSIS-RELATED GROUPS;
DISEASE PROGRESSION;
EUROPE;
FEMALE;
HUMANS;
JOINTS;
MALE;
METHOTREXATE;
MIDDLE AGED;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
RHEUMATOLOGY;
SENSITIVITY AND SPECIFICITY;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 84874403835
PISSN: 00034967
EISSN: 14682060
Source Type: Journal
DOI: 10.1136/annrheumdis-2012-202778 Document Type: Article |
Times cited : (21)
|
References (8)
|